Calcium-dependent and aspartyl proteases in neurodegeneration and ageing in C. elegans

Ageing Research Reviews

Volumn 2, Issue 4, 2003, Pages 451-471

  Samara, Chrysanthi ^a   Tavernarakis, Nektarios ^a  

^a INSTITUTE OF MOLECULAR BIOLOGY AND BIOTECHNOLOGY   (Greece)

Author keywords

Acidosis; Alzheimer's disease; Calpain; Cathepsin D; Lysosome; Necrosis

Indexed keywords

ASPARTIC PROTEINASE; CALCIUM; CALPAIN; CATHEPSIN; LYSOSOME ENZYME;

AGING; ALZHEIMER DISEASE; CAENORHABDITIS ELEGANS; CALCIUM HOMEOSTASIS; CELL DEATH; DEGENERATIVE DISEASE; DROSOPHILA MELANOGASTER; HUMAN; HUNTINGTON CHOREA; MOLECULAR BIOLOGY; NERVE CELL DEGENERATION; NONHUMAN; PARKINSON DISEASE; PROTEIN DEGRADATION; REVIEW; STROKE;

CAENORHABDITIS; CAENORHABDITIS ELEGANS; DROSOPHILA MELANOGASTER; MELANOGASTER;

EID: 0141539596     PISSN: 15681637     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1568-1637(03)00032-1     Document Type: Review

References (125)

1. Adamec E., Mohan P.S., Cataldo A.M., Vonsattel J.P., Nixon R.A. Up-regulation of the lysosomal system in experimental models of neuronal injury: implications for Alzheimer's disease. Neuroscience. 100:2000;663-675.
2. Aki T., Yoshida K., Fujimiya T. Phosphoinositide 3-kinase accelerates calpain-dependent proteolysis of fodrin during hypoxic cell death. J. Biochem. (Tokyo). 132:2002;921-926.
3. Apfeld J., Kenyon C. Regulation of lifespan by sensory perception in Caenorhabditis elegans. Nature. 402:1999;804-809.
4. Baumeister R., Ge L. The worm in us - Caenorhabditis elegans as a model of human disease. Trends Biotechnol. 20:2002;147-148.
5. Berger A.J., Hart A.C., Kaplan J.M. G alphas-induced neurodegeneration in Caenorhabditis elegans. J. Neurosci. 18:1998;2871-2880.
6. Berridge M.J., Lipp P., Bootman M.D. The versatility and universality of calcium signalling. Nat. Rev. Mol. Cell Biol. 1:2000;11-21.
7. Bi X., Haque T.S., Zhou J., Skillman A.G., Lin B., Lee C.E., Kuntz I.D., Ellman J.A., Lynch G. Novel cathepsin D inhibitors block the formation of hyperphosphorylated tau fragments in hippocampus. J. Neurochem. 74:2000a;1469-1477.
8. Bi X., Yong A.P., Zhou J., Gall C.M., Lynch G. Regionally selective changes in brain lysosomes occur in the transition from young adulthood to middle age in rats. Neuroscience. 97:2000b;395-404.
9. Blondet B., Carpentier G., Ait-Ikhlef A., Murawsky M., Rieger F. Motoneuron morphological alterations before and after the onset of the disease in the wobbler mouse. Brain Res. 930:2002;53-57.
10. Bolanowski M.A., Russell R.L., Jacobson L.A. Quantitative measures of aging in the nematode Caenorhabditis elegans. I. Population and longitudinal studies of two behavioral parameters. Mech. Ageing Dev. 15:1981;279-295.
11. Brand M.D. Uncoupling to survive? The role of mitochondrial inefficiency in ageing. Exp. Gerontol. 35:2000;811-820.
12. Canessa C.M., Horisberger J.D., Rossier B.C. Epithelial sodium channel related to proteins involved in neurodegeneration. Nature. 361:1993;467-470.
13. Carafoli E. Calcium signaling: a tale for all seasons. Proc. Natl. Acad. Sci. U.S.A. 99:2002;1115-1122.
14. Chalfie M., Wolinsky E. The identification and suppression of inherited neurodegeneration in Caenorhabditis elegans. Nature. 345:1990;410-416.
15. Chalfie M., Driscoll M., Huang M. Degenerin similarities. Nature. 361:1993;504.
16. Chalfie M., Tu Y., Euskirchen G., Ward W.W., Prasher D.C. Green fluorescent protein as a marker for gene expression. Science. 263:1995;802-805.
17. + channel MDEG1. J. Biol. Chem. 273:1998;15418-15422.
18. Chan S.L., Mattson M.P. Caspase and calpain substrates: roles in synaptic plasticity and cell death. J. Neurosci. Res. 58:1999;167-190.
19. Choi D.W. Excitotoxic cell death. J. Neurobiol. 23:1992;1261-1276.
20. Chondrogianni N., Fragoulis E.G., Gonos E.S. Protein degradation during aging: the lysosome-, the calpain- and the proteasome-dependent cellular proteolytic systems. Biogerontology. 3:2002;121-123.
21. Cooper J.D., Messer A., Feng A.K., Chua-Couzens J., Mobley W.C. Apparent loss and hypertrophy of interneurons in a mouse model of neuronal ceroid lipofuscinosis: evidence for partial response to insulin-like growth factor-1 treatment. J. Neurosci. 19:1999;2556-2567.
22. Crawford F.C., Freeman M.J., Schinka J., Abdullah L.I., Richards D., Sevush S., Duara R., Mullan M.J. The genetic association between cathepsin D and Alzheimer's disease. Neurosci. Lett. 289:2000;61-65.
23. Darr D., Fridovich I. Adaptation to oxidative stress in young, but not in mature or old, Caenorhabditis elegans. Free Radic. Biol. Med. 18:1995;195-201.
24. Decker R.S., Poole A.R., Crie J.S., Dingle J.T., Wildenthal K. Lysosomal alterations in hypoxic and reoxygenated hearts. II. Immunohistochemical and biochemical changes in cathepsin D. Am. J. Pathol. 98:1980;445-456.
25. Driscoll M., Chalfie M. The mec-4 gene is a member of a family of Caenorhabditis elegans genes that can mutate to induce neuronal degeneration. Nature. 349:1991;588-593.
26. Duan W., Mattson M.P. Dietary restriction and 2-deoxyglucose administration improve behavioral outcome and reduce degeneration of dopaminergic neurons in models of Parkinson's disease. J. Neurosci. Res. 57(2):1999;195-206.
27. Duan W., Guo Z., Jiang H., Ware M., Li X.J., Mattson M.P. Dietary restriction normalizes glucose metabolism and BDNF levels, slows disease progression, and increases survival in huntingtin mutant mice. Proc. Natl. Acad. Sci. U.S.A. 100(5):2003;2911-2916.
28. Duhon S.A., Johnson T.E. Movement as an index of vitality: comparing wild type and the age-1 mutant of Caenorhabditis elegans. J. Gerontol. A Biol. Sci. Med. Sci. 50:1995;B254-B261.
29. Ellis H.M., Horvitz H.R. Genetic control of programmed cell death in the nematode C. elegans. Cell. 44:1986;817-829.
30. Epstein F.H. Sudden death - epidemiological aspects. Cor. Vasa. 28:1986;83-89.
31. Fire A. RNA-triggered gene silencing. Trends Genet. 15:1999;358-363.
32. Fire A., Harrison S.W., Dixon D. A modular set of lacZ fusion vectors for studying gene expression in Caenorhabditis elegans. Gene. 93:1990;189-198.
33. Friedman D.B., Johnson T.E. A mutation in the age-1 gene in Caenorhabditis elegans lengthens life and reduces hermaphrodite fertility. Genetics. 118:1988a;75-86.
34. Friedman D.B., Johnson T.E. Three mutants that extend both mean and maximum life span of the nematode, Caenorhabditis elegans, define the age-1 gene. J. Gerontol. 43:1988b;B102-B109.
35. Gems D. Nematode ageing: putting metabolic theories to the test. Curr. Biol. 9:1999;R614-R616.
36. Gems D., Riddle D.L. Defining wild-type life span in Caenorhabditis elegans. J. Gerontol. A Biol. Sci. Med. Sci. 55:2000;B215-B219.
37. Grynspan F., Griffin W.R., Cataldo A., Katayama S., Nixon R.A. Active site-directed antibodies identify calpain II as an early-appearing and pervasive component of neurofibrillary pathology in Alzheimer's disease. Brain Res. 763:1997;145-158.
38. Guarente L., Kenyon C. Genetic pathways that regulate ageing in model organisms. Nature. 408:2000;255-262.
39. Hall D.H., Gu G., Garcia-Anoveros J., Gong L., Chalfie M., Driscoll M. Neuropathology of degenerative cell death in Caenorhabditis elegans. J. Neurosci. 17:1997;1033-1045.
40. Harbinder S., Tavernarakis N., Herndon L.A., Kinnell M., Xu S.Q., Fire A., Driscoll M. Genetically targeted cell disruption in Caenorhabditis elegans. Proc. Natl. Acad. Sci. U.S.A. 94:1997;13128-13133.
41. Haug L.S., Ostvold A.C., Cowburn R.F., Garlind A., Winblad B., Bogdanovich N., Walaas S.I. Decreased inositol (1,4,5)-trisphosphate receptor levels in Alzheimer's disease cerebral cortex: selectivity of changes and possible correlation to pathological severity. Neurodegeneration. 5:1996;169-176.
42. Hedgecock E.M., Sulston J.E., Thomson J.N. Mutations affecting programmed cell deaths in the nematode Caenorhabditis elegans. Science. 220:1983;1277-1279.
43. Hekimi S., Lakowski B., Barnes T.M., Ewbank J.J. Molecular genetics of life span in C. elegans: how much does it teach us? Trends Genet. 14:1998;14-20.
44. Hengartner M.O. The biochemistry of apoptosis. Nature. 407:2000;770-776.
45. Hengartner M.O. Apoptosis: corralling the corpses. Cell. 104:2001;325-328.
46. Heydari A.R., Takahashi R., Gutsmann A., You S., Richardson A. Hsp70 and aging. Experientia. 50:1994;1092-1098.
47. Honda S., Ishii N., Suzuki K., Matsuo M. Oxygen-dependent perturbation of life span and aging rate in the nematode. J. Gerontol. 48:1993;B57-B61.
48. Huang Y., Wang K.K. The calpain family and human disease. Trends Mol. Med. 7:2001;355-362.
49. Jiang C.H., Tsien J.Z., Schultz P.G., Hu Y. The effects of aging on gene expression in the hypothalamus and cortex of mice. Proc. Natl. Acad. Sci. U.S.A. 98:2001;1930-1934.
50. Kamath R.S., Fraser A.G., Dong Y., Poulin G., Durbin R., Gotta M., Kanapin A., Le Bot N., Moreno S., Sohrmann M., Welchman D.P., Zipperlen P., Ahringer J. Systematic functional analysis of the Caenorhabditis elegans genome using RNAi. Nature. 421:2003;231-237.
51. Karlsson J.O., Blennow K., Janson I., Blomgren K., Karlsson I., Regland B., Wallin A., Gottfries C.G. Increased proteolytic activity in lymphocytes from patients with early onset Alzheimer's disease. Neurobiol. Aging. 16:1995;901-906.
52. Kenyon C., Chang J., Gensch E., Rudner A., Tabtiang R. A C. elegans mutant that lives twice as long as wild type. Nature. 366:1993;461-464.
53. Kim S.K., Lund J., Kiraly M., Duke K., Jiang M., Stuart J.M., Eizinger A., Wylie B.N., Davidson G.S. A gene expression map for Caenorhabditis elegans. Science. 293:2001;2087-2092.
54. Kim M.J., Jo D.G., Hong G.S., Kim B.J., Lai M., Cho D.H., Kim K.W., Bandyopadhyay A., Hong Y.M., Kim do H., Cho C., Liu J.O., Snyder S.H., Jung Y.K. Calpain-dependent cleavage of cain/cabin 1 activates calcineurin to mediate calcium-triggered cell death. Proc. Natl. Acad. Sci. U.S.A. 99:2002;9870-9875.
55. Klass M.R. Aging in the nematode Caenorhabditis elegans: major biological and environmental factors influencing life span. Mech. Ageing. Dev. 6:1977;413-429.
56. Klass M., Hirsh D. Non-ageing developmental variant of Caenorhabditis elegans. Nature. 260:1976;523-525.
57. Korswagen H.C., Park J.H., Ohshima Y., Plasterk R.H. An activating mutation in a Caenorhabditis elegans Gs protein induces neural degeneration. Genes. Dev. 11:1997;1493-1503.
58. Lakowski B., Hekimi S. The genetics of caloric restriction in Caenorhabditis elegans. Proc. Natl. Acad. Sci. U.S.A. 95:1998;13091-13096.
59. Larsen P.L. Aging and resistance to oxidative damage in Caenorhabditis elegans. Proc. Natl. Acad. Sci. U.S.A. 90:1993;8905-8909.
60. Larsen P.L., Albert P.S., Riddle D.L. Genes that regulate both development and longevity in Caenorhabditis elegans. Genetics. 139:1995;1567-1583.
61. Lee J.M., Zipfel G.J., Choi D.W. The changing landscape of ischaemic brain injury mechanisms. Nature. 399:1999;A7-A14.
62. Lee C.K., Weindruch R., Prolla T.A. Gene-expression profile of the ageing brain in mice. Nat. Genet. 25:2000a;294-297.
63. Lee M.S., Kwon Y.T., Li M., Peng J., Friedlander R.M., Tsai L.H. Neurotoxicity induces cleavage of p35 to p25 by calpain. Nature. 405:2000b;360-364.
64. Leist M., Jaattela M. Four deaths and a funeral: from caspases to alternative mechanisms. Nat. Rev. Mol. Cell Biol. 2:2001;589-598.
65. Link C.D. Transgenic invertebrate models of age-associated neurodegenerative diseases. Mech. Ageing. Dev. 122:2001;1639-1649.
66. Lipton P. Ischemic cell death in brain neurons. Physiol. Rev. 79:1999;1431-1568.
67. Lithgow G.J., White T.M., Melov S., Johnson T.E. Thermotolerance and extended life-span conferred by single-gene mutations and induced by thermal stress. Proc. Natl. Acad. Sci. U.S.A. 92:1995;7540-7544.
68. Liu L.X., Spoerke J.M., Mulligan E.L., Chen J., Reardon B., Westlund B., Sun L., Abel K., Armstrong B., Hardiman G., King J., McCague L., Basson M., Clover R., Johnson C.D. High-throughput isolation of Caenorhabditis elegans deletion mutants. Genome Res. 9:1999;859-867.
69. Maccioni R.B., Munoz J.P., Barbeito L. The molecular bases of Alzheimer's disease and other neurodegenerative disorders. Arch. Med. Res. 32:2001;367-381.
70. Majno G., Joris I. Apoptosis, oncosis, and necrosis. An overview of cell death. Am. J. Pathol. 146:1995;3-15.
71. Manya H., Inomata M., Fujimori T., Dohmae N., Sato Y., Takio K., Nabeshima Y., Endo T. Klotho protein deficiency leads to overactivation of mu-calpain. J. Biol. Chem. 277:2002;35503-35508.
72. Martin S.J., O'Brien G.A., Nishioka W.K., McGahon A.J., Mahboubi A., Saido T.C., Green D.R. Proteolysis of fodrin (non-erythroid spectrin) during apoptosis. J. Biol. Chem. 270:1995;6425-6428.
73. Martin G.M., Austad S.N., Johnson T.E. Genetic analysis of ageing: role of oxidative damage and environmental stresses. Nat. Genet. 13:1996;25-34.
74. Masliah E., Iimoto D.S., Saitoh T., Hansen L.A., Terry R.D. Increased immunoreactivity of brain spectrin in Alzheimer disease: a marker for synapse loss? Brain Res. 531:1990;36-44.
75. McCollum A.T., Nasr P., Estus S. Calpain activates caspase-3 during UV-induced neuronal death but only calpain is necessary for death. J. Neurochem. 82:2002;1208-1220.
76. Mello C.C., Kramer J.M., Stinchcomb D., Ambros V. Efficient gene transfer in C. elegans: extrachromosomal maintenance and integration of transforming sequences. EMBO J. 10:1991;3959-3970.
77. Melov S. Mitochondrial oxidative stress. Physiologic consequences and potential for a role in aging. Ann. NY Acad. Sci. 908:2000;219-225.
78. Melov S., Hertz G.Z., Stormo G.D., Johnson T.E. Detection of deletions in the mitochondrial genome of Caenorhabditis elegans. Nucleic Acids Res. 22:1994;1075-1078.
79. Melov S., Ravenscroft J., Malik S., Gill M.S., Walker D.W., Clayton P.E., Wallace D.C., Malfroy B., Doctrow S.R., Lithgow G.J. Extension of life-span with superoxide dismutase/catalase mimetics. Science. 289:2000;1567-1569.
80. Merker K., Stolzing A., Grune T. Proteolysis, caloric restriction and aging. Mech. Ageing Dev. 122:2001;595-615.
81. Mo J.Q., Hom D.G., Andersen J.K. Decreases in protective enzymes correlates with increased oxidative damage in the aging mouse brain. Mech. Ageing Dev. 81:1995;73-82.
82. Mouatt-Prigent A., Karlsson J.O., Agid Y., Hirsch E.C. Increased M-calpain expression in the mesencephalon of patients with Parkinson's disease but not in other neurodegenerative disorders involving the mesencephalon: a role in nerve cell death? Neuroscience. 73:1996;979-987.
83. Nilsson E., Alafuzoff I., Blennow K., Blomgren K., Hall C.M., Janson I., Karlsson I., Wallin A., Gottfries C.G., Karlsson J.O. Calpain and calpastatin in normal and Alzheimer-degenerated human brain tissue. Neurobiol. Aging. 11:1990;425-431.
84. Nixon R.A. A "protease activation cascade" in the pathogenesis of Alzheimer's disease. Ann. NY Acad. Sci. 924:2000;117-131.
85. Oh-Ishi S., Kizaki T., Yamashita H., Nagata N., Suzuki K., Taniguchi N., Ohno H. Alterations of superoxide dismutase iso-enzyme activity, content, and mRNA expression with aging in rat skeletal muscle. Mech. Ageing Dev. 84:1995;65-76.
86. Prasanna H.R., Lane R.S. Protein degradation in aged nematodes (Turbatrix aceti). Biochem. Biophys. Res. Commun. 86:1979;552-559.
87. Rattan S.I., Clark B.F. Intra-cellular protein synthesis, modifications and aging. Biochem. Soc. Trans. 24:1996;1043-1049.
88. Reznick A.Z., Gershon D. The effect of age on the protein degradation system in the nematode Turbatrix aceti. Mech. Ageing Dev. 11:1979;403-415.
89. Rosenberger R.F. Senescence and the accumulation of abnormal proteins. Mutat. Res. 256:1991;255-262.
90. Sarkis G.J., Ashcom J.D., Hawdon J.M., Jacobson L.A. Decline in protease activities with age in the nematode Caenorhabditis elegans. Mech. Ageing Dev. 45:1988;191-201.
91. Sato M., Tani E., Matsumoto T., Fujikawa H., Imajoh-Ohmi S. Generation of the catalytic fragment of protein kinase C alpha in spastic canine basilar artery. J. Neurosurg. 87:1997;752-756.
92. Scott B.A., Avidan M.S., Crowder C.M. Regulation of hypoxic death in C. elegans by the insulin/IGF receptor homolog DAF-2. Science. 296:2002;2388-2391.
93. Sharma H.K., Prasanna H.R., Lane R.S., Rothstein M. The effect of age on enolase turnover in the free-living nematode, Turbatrix aceti. Arch. Biochem. Biophys. 194:1979;275-282.
94. Shea T.B., Spencer M.J., Beermann M.L., Cressman C.M., Nixon R.A. Calcium influx into human neuroblastoma cells induces ALZ-50 immunoreactivity: involvement of calpain-mediated hydrolysis of protein kinase C. J. Neurochem. 66:1996;1539-1549.
95. Sokol S.B., Kuwabara P.E. Proteolysis in Caenorhabditis elegans sex determination: cleavage of TRA-2A by TRA-3. Genes Dev. 14:2000;901-906.
96. Sorimachi H., Ishiura S., Suzuki K. Structure and physiological function of calpains. Biochem. J. 328(Pt 3):1997;721-732.
97. Stadtman E.R. Protein modification in aging. J. Gerontol. 43:1988;B112-B120.
98. Stadtman E.R. Protein oxidation and aging. Science. 257:1992;1220-1224.
99. Stryer, L., 1988. Biochemistry. Freeman, New York.
100. Stys P.K., Jiang Q. Calpain-dependent neurofilament breakdown in anoxic and ischemic rat central axons. Neurosci. Lett. 328:2002;150-154.
101. Sulston J.E., Horvitz H.R. Post embriyonic cell lineages of the nematode Caenorhabditis elegans. Dev. Biol. 56:1977;110-156.
102. Sulston J.E., Schierenberg E., White J.G., Thomson J.N. The embryonic cell lineage of the nematode Caenorhabditis elegans. Dev. Biol. 100:1983;64-119.
103. Syntichaki P., Tavernarakis N. Death by necrosis. Uncontrollable catastrophe, or is there order behind the chaos? EMBO Rep. 3:2002;604-609.
104. Syntichaki P., Xu K., Driscoll M., Tavernarakis N. Specific aspartyl and calpain proteases are required for neurodegeneration in C. elegans. Nature. 419:2002;939-944.
105. Takemura H., Hughes A.R., Thastrup O., Putney J.W. Jr. Activation of calcium entry by the tumor promoter thapsigargin in parotid acinar cells. Evidence that an intra-cellular calcium pool and not an inositol phosphate regulates calcium fluxes at the plasma membrane. J. Biol. Chem. 264:1989;12266-12271.
106. Tavernarakis, N., Driscoll, M., 2001a. Cell/neuron degeneration. In: Brenner, S., Miller, J. (Eds.), The Encyclopedia of Genetics, vol. 1. Academic Press, New York, NY.
107. Tavernarakis N., Driscoll M. Degenerins. At the core of the metazoan mechanotransducer? Ann. NY Acad. Sci. 940:2001b;28-41.
108. Tavernarakis N., Driscoll M. Caloric restriction and lifespan: a role for protein turnover? Mech. Ageing Dev. 123:2002;215-229.
109. Taylor J.P., Hardy J., Fischbeck K.H. Toxic proteins in neurodegenerative disease. Science. 296:2002;1991-1995.
110. Tcherepanova I., Bhattacharyya L., Rubin C.S., Freedman J.H. Aspartic proteases from the nematode Caenorhabditis elegans. Structural organization and developmental and cell-specific expression of asp-1. J. Biol. Chem. 275:2000;26359-26369.
111. The C. elegans Sequencing Consortium, 1998. Genome sequence of the nematode C. elegans: a platform for investigating biology. Science 282, 2012-2018.
112. Treinin M., Chalfie M. A mutated acetylcholine receptor subunit causes neuronal degeneration in C. elegans. Neuron. 14:1995;871-877.
113. Van Voorhies W.A., Ward S. Genetic and environmental conditions that increase longevity in Caenorhabditis elegans decrease metabolic rate. Proc. Natl. Acad. Sci. U.S.A. 96:1999;11399-11403.
114. Van Voorhies W.A., Ward S. Broad oxygen tolerance in the nematode Caenorhabditis elegans. J. Exp. Biol. 203(Pt 16):2000;2467-2478.
115. Vanderklish P.W., Bahr B.A. The pathogenic activation of calpain: a marker and mediator of cellular toxicity and disease states. Int. J. Exp. Pathol. 81:2000;323-339.
116. Vanfleteren J.R., Braeckman B.P. Mechanisms of life span determination in Caenorhabditis elegans. Neurobiol. Aging. 20:1999;487-502.
117. Vanfleteren J.R., De Vreese A. The gerontogenes age-1 and daf-2 determine metabolic rate potential in aging Caenorhabditis elegans. FASEB J. 9:1995;1355-1361.
118. Vanfleteren J.R., Braeckman B.P., Roelens I., De Vreese A. Age-specific modulation of light production potential, and alkaline phosphatase and protein tyrosine kinase activities in various age mutants of Caenorhabditis elegans. J. Gerontol. A Biol. Sci. Med. Sci. 53:1998;B380-B390.
119. Vohra B.P., James T.J., Sharma S.P., Kansal V.K., Chudhary A., Gupta S.K. Dark neurons in the ageing cerebellum: their mode of formation and effect of Maharishi Amrit Kalash. Biogerontology. 3:2002;347-354.
120. Ward W.F. The relentless effects of the aging process on protein turnover. Biogerontology. 1:2000;195-199.
121. White J.G., Southgate E., Thomson J.N., Brenner S. The structure of the ventral nerve cord of Caenorhabditis elegans. Philos. Trans. R. Soc. Lond. B Biol. Sci. 275:1976;327-348.
122. Xu K., Tavernarakis N., Driscoll M. Necrotic cell death in C. elegans requires the function of calreticulin and regulators of Ca(2+) release from the endoplasmic reticulum. Neuron. 31:2001;957-971.
123. Yamashima T. Implication of cysteine proteases calpain, cathepsin and caspase in ischemic neuronal death of primates. Prog. Neurobiol. 62:2000;273-295.
124. Yoshida M., Yamashima T., Zhao L., Tsuchiya K., Kohda Y., Tonchev A.B., Matsuda M., Kominami E. Primate neurons show different vulnerability to transient ischemia and response to cathepsin inhibition. Acta Neuropathol. (Berl.). 104:2002;267-272.
125. Yu Z.F., Mattson M.P. Dietary restriction and 2-deoxyglucose administration reduce focal ischemic brain damage and improve behavioral outcome: evidence for a preconditioning mechanism. J. Neurosci. Res. 57(6):1999;830-839.